49-200-210MG

MilliporeSigma™ Calbiochem™ NOX1 Inhibitor, ML171

Manufacturer: MilliporeSigma™

CAS Number: 6631-94-3

Select a Size

Pack Size SKU Availability Price
Each of 1 49-200-210MG-Each-of-1 In Stock ₹ 10,963.91

49-200-210MG - Each of 1

₹ 10,963.91

In Stock

Quantity

1

Base Price: ₹ 10,963.91

GST (18%): ₹ 1,973.504

Total Price: ₹ 12,937.414

Color

Dark Yellow-orange

Molecular Formula

C14H11NOS

Quantity

10 mg

CAS

6631-94-3

Form

Powder

Other Options

Image Product Name Manufacturer Price Range
Selleck Chemical LLC 2-Acetylphenothiazine (ML171) 25mg 6631-94-3 2-APT
-- ₹ 10,359.60
Medchemexpress LLC HY-12805 100mg Medchemexpress, ML171 CAS:6631-94-3 Purity:>98%
-- ₹ 3,284.10
ML171
-- ₹ 3,916.00 - ₹ 43,343.00

Related Products

Img

MilliporeSigma™

50-604-70001

--

Img

MilliporeSigma™

41-251-010MG

--

Img

MilliporeSigma™

53-065-40001

--

Img

MilliporeSigma™

53-051-00001

--

Img

MilliporeSigma™

61-485-210MG

--

Img

MilliporeSigma™

53-065-00001

--

Img

MilliporeSigma™

53-149-20001

--

Img

MilliporeSigma™

50-048-90001

--

Description

  • A highly selective, cell-permeable, and reversible 2-acetylphenothiazine that is shown to inhibit NADPH Oxidase-1 (Nox1) (IC 50 = 0.129μM, and 0.25μM) in human HT29 and HEK293 cell-based assays, respectively
  • Unlike most other currently used Nox inhibitors, it only has marginal activity on other cellular ROS-producing enzymes and receptors including the other Nox isoforms (IC 50 = 5μM, 3μM and 5μM for Nox2, Nox3, and Nox4, respectively) and xanthine oxidase, XO, (IC 50 = 5.5μM) in HEK293 cell-based assays
  • It is also shown to block Nox1-dependent ROS generation in HEK293 cultures dose-dependently at concentrations up to ∽ 100nM; however, its inhibitory effect is reversed through over-expression of Nox1, thereby suggesting that this compound is highly selective for Nox1, with little effect against Nox2-dependent ROS generation (IC 50 > 10μM)
  • Qualitatively, it displays an inhibitory effect against SrcYF-induced ECM-degrading invadopodia formation in DLD1 Human Colon Cancer Cells.